Dabigatran Etexilate Mesylate

CAS 872728-81-9 37 current records 3 historicalSmall Molecule

Who holds supplier records for Dabigatran Etexilate Mesylate? 37 organisations hold a current record for Dabigatran Etexilate Mesylate: an active US FDA Type II Drug Master File or a CEP. A further 3 organisations have only historical (inactive) DMF filings. 18 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (24), China (7), Netherlands (1), Canada (1) and 2 other countries (2); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Dabigatran Etexilate Mesylate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/dabigatran-etexilate-mesylate

Reading the evidence

  • 37 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    24 of the 35 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 22 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (37)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Dabigatran Etexilate Mesylate. Country is the organisation's recorded country, not necessarily the manufacturing site.

India24China7Netherlands1Canada1Spain1Slovenia1Country not recorded for 2
Need Dabigatran Etexilate Mesylate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (18)

Certificates of Suitability on the EDQM register for Dabigatran Etexilate Mesylate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 21 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
LAURUS LABS LIMITED HyderabadIN
CEP 2025-167 - Rev 00
Dabigatran etexilate mesilate
Nov 2026—
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. TaizhouCN
CEP 2023-458 - Rev 01
Dabigatran etexilate mesilate, Micronised and non-micronised
Sept 2026Inspected May 2026
Italy
METROCHEM API PRIVATE LIMITED HyderabadIN
CEP 2024-130 - Rev 01
Dabigatran etexilate mesilate
Jul 2026—
QUIMICA SINTETICA S.A. Alcala De HenaresES
CEP 2025-197 - Rev 00
Dabigatran etexilate mesilate, Non-micronised, Micronised
Jun 2026Inspected Apr 2025
Spain
SICHUAN QINGMU PHARMACEUTICAL CO., LTD. Meishan CityCN
CEP 2024-115 - Rev 00
Dabigatran etexilate mesilate
Jun 2026—
ALEMBIC PHARMACEUTICALS LIMITED VadodaraIN
CEP 2024-081 - Rev 01
Dabigatran etexilate mesilate, Form-I
May 2026—
DR. REDDY'S LABORATORIES LIMITED HyderabadIN
CEP 2024-365 - Rev 00
Dabigatran etexilate mesilate, Form 1, Process II
May 2026—
PIRAMAL PHARMA LIMITED Digwal VillageIN
CEP 2024-090 - Rev 00
Dabigatran etexilate mesilate, Form-I
Mar 2026Inspected Jun 2025
Netherlands
TAPI NL B.V. AmsterdamNL
CEP 2025-606 - Rev 00
Dabigatran etexilate mesilate, Form I, ACL
Mar 2026—
ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD. Taizhou CityCN
CEP 2024-073 - Rev 02
Dabigatran etexilate mesilate, Micronised, non-micronised
Dec 2025—
HIKAL LIMITED BangaloreIN
CEP 2024-363 - Rev 00
Dabigatran etexilate mesilate
Dec 2025Inspected Nov 2025
Switzerland
AURORE LIFE SCIENCES PRIVATE LIMITED HyderabadIN
CEP 2023-382 - Rev 00
Dabigatran etexilate mesilate
Nov 2025—
KRKA TOVARNA ZDRAVIL D.D. NOVO MESTO Novo mestoSI
CEP 2024-152 - Rev 00
Dabigatran etexilate mesilate, Micronised
Oct 2025Inspected Jul 2025
Slovenia
BIOCON LIMITED PashamylaramIN
CEP 2024-046 - Rev 00
Dabigatran etexilate mesilate, Form-I
Oct 2025—
Changzhou Pharmaceutical Factory ChangzhouCN
CEP 2023-435 - Rev 00
Dabigatran etexilate mesilate
Aug 2025Inspected Apr 2025
Italy
ZYDUS LIFESCIENCES LIMITED VadodaraIN
CEP 2024-262 - Rev 00
Dabigatran etexilate mesilate, Form-I
Jun 2025—
MSN LIFE SCIENCES PRIVATE LIMITED Chandampet VillageIN
CEP 2024-026 - Rev 00
Dabigatran etexilate mesilate, Crystalline Form-I, micronised and non-micronised
Dec 2024Inspected Oct 2025
Slovakia
MSN LABORATORIES PRIVATE LIMITED Rudraram VillageIN
CEP 2024-012 - Rev 00
Dabigatran etexilate mesilate, Crystalline Form-I, Micronised and Non-micronised
Oct 2024—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (3)

Organisations whose Type II DMFs for Dabigatran Etexilate Mesylate are no longer active. These show a past filing, not current supply.

Show all 3 historical records
  • SICHUAN RENAN PHARMACEUTICAL CO LTD
    Inactive DMF 38099 · filed Apr 2023
  • ESTEVE QUIMICA SA
    Inactive DMF 29270 · filed Jun 2015
  • India · Inactive DMF 27892 · filed Mar 2014

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Dabigatran Etexilate Mesylate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1615369).

Chemical identity

IUPAC name
ethyl 3-[[2-[[4-[(E)-N'-hexoxycarbonylcarbamimidoyl]anilino]methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoate;methanesulfonic acid
Canonical SMILES
CCCCCCOC(=O)/N=C(\C1=CC=C(C=C1)NCC2=NC3=C(N2C)C=CC(=C3)C(=O)N(CCC(=O)OCC)C4=CC=CC=N4)/N.CS(=O)(=O)O
InChIKey
XETBXHPXHHOLOE-UHFFFAOYSA-N
Synonyms
BIBR 1048 MS, BIBR-1048-MS, Dabigatran etexilate accord, Dabigatran etexilate leon farma, Dabigatran etexilate mesilate, Dabigatran etexilate mesylate, Pradaxa, Pradaxa (dabigatran etexilate mesylate), Rendix, Pradaxa, Dabigatran etexilate mesylate, BS-1008

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Direct Thrombin Inhibitor
Mechanism of action
Thrombin Inhibitors

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Dabigatran Etexilate Mesylate?

37 organisations hold an active US FDA Type II Drug Master File or a CEP for Dabigatran Etexilate Mesylate: Hetero Drugs Limited (India), Neuland Laboratories Limited (India), Alembic Pharmaceuticals Limited (India), Aurore Life Sciences (India), Biocon Limited (India), CHANGZHOU PHARMACEUTICAL FACTORY (China), Dr. Reddy's Laboratories Ltd. (India) and HIKAL LTD (India), and 29 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Dabigatran Etexilate Mesylate Drug Master Files are active?

Hetero Drugs Limited (DMF 28177, 44582), Neuland Laboratories Limited (DMF 28352, 38769), Alembic Pharmaceuticals Limited (DMF 27781), Aurore Life Sciences (DMF 37002), Biocon Limited (DMF 33112), CHANGZHOU PHARMACEUTICAL FACTORY (DMF 37528), Dr. Reddy's Laboratories Ltd. (DMF 27960) and HIKAL LTD (DMF 40122, 31613) and 25 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Dabigatran Etexilate Mesylate records mean?

3 organisations have only inactive Type II DMFs for Dabigatran Etexilate Mesylate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Dabigatran Etexilate Mesylate have a European Certificate of Suitability?

Yes. 18 organisations hold a valid CEP for Dabigatran Etexilate Mesylate on the EDQM register, including LAURUS LABS LIMITED Hyderabad (IN), ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Taizhou (CN), METROCHEM API PRIVATE LIMITED Hyderabad (IN), QUIMICA SINTETICA S.A. Alcala De Henares (ES), SICHUAN QINGMU PHARMACEUTICAL CO., LTD. Meishan City (CN) and ALEMBIC PHARMACEUTICALS LIMITED Vadodara (IN) and 12 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Dabigatran Etexilate Mesylate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Dabigatran Etexilate Mesylate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.